Results for tag: "Thrombate"

The Thrombate market is a subset of the cardiovascular drugs market, focusing on antithrombotic drugs. These drugs are used to prevent and treat thrombosis, a condition in which blood clots form in the blood vessels. Thrombosis can lead to serious health complications, such as stroke, heart attack, and pulmonary embolism. Thrombate drugs are used to reduce the risk of these complications by preventing the formation of blood clots. The Thrombate market is highly competitive, with many large pharmaceutical companies offering a variety of products. These products include anticoagulants, antiplatelet agents, and fibrinolytics. Anticoagulants are used to prevent the formation of blood clots, while antiplatelet agents are used to reduce the risk of clotting. Fibrinolytics are used to dissolve existing clots. Some of the major companies in the Thrombate market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. These companies offer a wide range of products, including anticoagulants, antiplatelet agents, and fibrinolytics. They also offer a variety of other cardiovascular drugs, such as statins, ACE inhibitors, and beta blockers. Show Less Read more